Maintaining Safe and Reliable Supply of Comparators during COVID19 As an agile, well-distributed and robust global supplier of Comparators for the biopharmaceutical industry, Inceptua is uniquely positioned to safely and…
Inceptua GroupMay 19, 2020
In clinical trials, a Comparator drug, either an investigational or marketed product, is often required to determine the efficacy relative to a drug that is already on the market. Safe,…
Inceptua GroupMarch 22, 2020
Press release: Oxurion and Inceptua Group enter global license agreement for the commercialization of JETREA® Oxurion announces the signing of a JETREA® global license agreement with Inceptua Group. JETREA® is…
Inceptua GroupMarch 13, 2020
Expanded Access as a Key Component in the Development and Launch Process On February 20, 2020, Inceptua hosted a webinar on industry trends in pre-approval access to medicines. You…
Stuart BellMarch 3, 2020
LUXEMBOURG / SAN FRANCISCO – 7th February 2020 – Inceptua, a global pharmaceutical company and service partner and Portola - US developer and manufacturer of therapeutic agents focusing on thrombosis…
Inceptua GroupFebruary 7, 2020
Inceptua has offices in both Japan and China where the regional Clinical Trial Services Team provides strategic sourcing and supply of clinical trial materials with associated clinical packaging and labelling…
Inceptua GroupFebruary 5, 2020
Dr. Stefan Fraenkel, Executive Vice President, Inceptua Pharma Understand how to commercialize via partnering in Europe and other markets outside of the USA. Dr. Stefan Fraenkel, Executive Vice President, Commercial…
Stefan FraenkelNovember 1, 2018